|
1
|
Chen YJ, Lin SC, Kao T, et al: Genome-wide
profiling of oral squamous cell carcinoma. J Pathol. 204:326–332.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pentenero M, Gandolfo S and Carrozzo M:
Importance of tumor thickness and depth of invasion in nodal
involvement and prognosis of oral squamous cell carcinoma: a review
of the literature. Head Neck. 27:1080–1091. 2005. View Article : Google Scholar
|
|
3
|
Myers JN, Elkins T, Roberts D and Byers
RM: Squamous cell carcinoma of the tongue in young adults:
increasing incidence and factors that predict treatment outcomes.
Otolaryngol Head Neck Surg. 122:44–51. 2000. View Article : Google Scholar
|
|
4
|
Chambers I, Colby D, Robertson M, et al:
Functional expression cloning of Nanog, a pluripotency sustaining
factor in embryonic stem cells. Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitsui K, Tokuzawa Y, Itoh H, et al: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar
|
|
6
|
Cavaleri F and Schöler HR: Nanog: a new
recruit to the embryonic stem cell orchestra. Cell. 113:551–552.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pan G and Thomson JA: Nanog and
transcriptional networks in embryonic stem cell pluripotency. Cell
Res. 17:42–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ezeh UI, Turek PJ, Reijo RA and Clark AT:
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are
expressed in both seminoma and breast carcinoma. Cancer.
104:2255–2265. 2005. View Article : Google Scholar
|
|
9
|
Meng HM, Zheng P, Wang XY, et al:
Overexpression of nanog predicts tumor progression and poor
prognosis in colorectal cancer. Cancer Biol Ther. 9:295–302. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu F, Dai C, Zhang R, Zhao Y, Peng S and
Jia C: Nanog: a potential biomarker for liver metastasis of
colorectal cancer. Dig Dis Sci. 57:2340–2346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsuoka J, Yashiro M, Sakurai K, et al:
Role of the stemness factor sox2, oct3/4, and nanog in gastric
carcinoma. J Surg Res. 174:130–135. 2012. View Article : Google Scholar
|
|
12
|
Tsai LL, Yu CC, Chang YC, Yu CH and Chou
MY: Markedly increased Oct4 and Nanog expression correlates with
cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol
Med. 40:621–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bourguignon LY, Earle C, Wong G, Spevak CC
and Krueger K: Stem cell marker (Nanog) and Stat-3 signaling
promote MicroRNA-21 expression and chemoresistance in
hyaluronan/CD44-activated head and neck squamous cell carcinoma
cells. Oncogene. 31:149–160. 2012. View Article : Google Scholar
|
|
14
|
Chiou SH, Yu CC, Huang CY, et al: Positive
correlations of oct-4 and nanog in oral cancer stem-like cells and
high-grade oral squamous cell carcinoma. Clin Cancer Res.
14:4085–4095. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133(+) cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
|
|
16
|
Sobin LH and Wittekind C: International
Union Against Cancer TNM classification of malignant tumors. 5th
edition. Wiley-Liss Publications; Hoboken, NJ: 1997
|
|
17
|
Dalerba P, Cho RW and Clarke MF: Cancer
Stem Cells: Models and Concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
19
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cell. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Costea DE, Tsinkalovsky O, Vintermyr OK,
Johannessen AC and Mackenzie IC: Cancer stem cells - new and
potentially important targets for the therapy of oral squamous cell
carcinoma. Oral Dis. 12:443–454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Locke M, Heywood M, Fawell S and Mackenzie
IC: Retention of intrinsic stem cell hierarchies in
carcinoma-derived cell lines. Cancer Res. 65:8944–8950. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Izumiya M, Kabashima A, Higuchi H, et al:
Chemoresistance is associated with cancer stem cell-like properties
and epithelial-to-mesenchymal transition in pancreatic cancer
cells. Anticancer Res. 32:3847–3853. 2012.PubMed/NCBI
|
|
23
|
Moon JH, Kwon S, Jun EK, et al:
Nanog-induced dedifferentiation of p53-deficient mouse astrocytes
into brain cancer stem-like cells. Biochem Biophys Res Commun.
412:175–181. 2011.PubMed/NCBI
|
|
24
|
Chen SL, Iddings DM, Scheri RP and Bilchik
AJ: Lymphatic mapping and sentinel node analysis: current concepts
and applications. CA Cancer J Clin. 56:292–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Trivedi NP, Ravindran HK, Sundram S, et
al: Pathologic evaluation of sentinel lymph nodes in oral squamous
cell carcinoma. Head Neck. 32:1437–1443. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kayahara H, Okuda M, Terakado N, Shintani
S and Hamakawa H: Non-randomized clinical study comparing
chemotherapy plus radiotherapy with radiotherapy alone in
neoadjuvant therapy for oral cancer. Gan To Kagaku Ryoho.
29:911–916. 2002.(In Japanese).
|
